Mosaic ImmunoEngineering Inc. (CPMV) intrinsic value & 10-year financials
Mosaic ImmunoEngineering Inc. (CPMV) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.33
- Market cap
- $2.3M
- Revenue (FY2025)
- —
- Revenue growth (10-yr CAGR)
- 106.9%
- ROIC (10-yr avg)
- 23.8%
- Free cash flow (FY2025)
- —
CPMV 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$687.8K | -$0.10 | — | — | 8.6% |
| FY2024 | — | -$922.0K | -$0.13 | — | — | 13.9% |
| FY2023 | — | -$1.0M | -$0.14 | — | — | 26.0% |
| FY2022 | — | -$2.4M | -$0.33 | — | — | 68.4% |
| FY2021 | — | -$3.7M | -$0.55 | — | — | 323.7% |
| FY2020 | — | -$1.1M | $0.00 | — | — | -90.9% |
| FY2019 | — | -$798.5K | $0.00 | -$760.8K | — | -38.1% |
| FY2018 | $0 | -$1.2M | $0.00 | -$881.8K | — | -39.0% |
| FY2017 | $3.0M | -$45.4K | $0.00 | -$1.3M | — | -1.2% |
| FY2016 | $1.4M | -$1.3M | $0.00 | -$1.6M | — | -33.8% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Mosaic ImmunoEngineering Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Mosaic ImmunoEngineering Inc. has historically struggled to out-earn its cost of capital, averaging just -8.3% ROIC.
Mosaic ImmunoEngineering Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Mosaic ImmunoEngineering Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-3.32 per share.